Press Releases
Filters
December 15, 2023
Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer
December 15, 2023
Viatris Shareholders Re-elect All Nominated Directors and Approve All Voting Matters at Annual Meeting of Shareholders
November 13, 2023
Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
October 30, 2023
Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance
October 23, 2023
Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a Row
October 10, 2023
Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023
October 1, 2023
Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA
Displaying 11 - 20 of 96